BRIEF published on 03/27/2025 at 18:05, 1 year 7 months ago Oxurion receives adjusted transparency notification Transparency Notification Shareholding Oxurion Atlas Special Opportunities II Brussels Stock Exchange
PRESS RELEASE published on 03/27/2025 at 18:00, 1 year 7 months ago Oxurion ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities II LLC, waardoor zij onder de drempel (5%) komen. Meer informatie beschikbaar op www.oxurion.com Transparantiekennisgeving Oxurion NV Netvliesaandoeningen Biofarmaceutisch Bedrijf Atlas Special Opportunities II LLC
PRESS RELEASE published on 03/27/2025 at 18:00, 1 year 7 months ago Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received an amended transparency notification from Atlas Special Opportunities II, LLC regarding the sale of voting securities. This press release replaces the one from March 18, 2025 Transparency Notification Euronext Brussels Oxurion NV Retinal Disease Therapies Atlas Special Opportunities II
BRIEF published on 03/24/2025 at 18:05, 1 year 7 months ago Oxurion Announces Capital Increase Following Convertible Bond Conversion Convertible Bonds Capital Increase Atlas Special Opportunities Ophthalmic Therapies Oxurion
BRIEF published on 03/24/2025 at 18:05, 1 year 7 months ago Oxurion annonce une augmentation de capital suite à la conversion d'obligations convertibles Obligations Convertibles Augmentation De Capital Thérapies Ophtalmiques Oxurion Opportunités Spéciales Atlas
PRESS RELEASE published on 03/24/2025 at 18:00, 1 year 7 months ago Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC converts bonds in Oxurion, resulting in EUR 150,000 capital increase. Oxurion focuses on developing therapeutics for vision care Capital Increase Therapeutics Vision Care Atlas Special Opportunities LLC Oxurion
PRESS RELEASE published on 03/24/2025 at 18:00, 1 year 7 months ago Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie Atlas Special Opportunities, LLC converte 6 obligaties in Oxurion, resulterend in EUR 150.000 kapitaalverhoging. Investering in innovatieve geneesmiddelen voor ouderen Euronext Brussel Kapitaalverhoging Atlas Special Opportunities Oxurion Innovatieve Geneesmiddelen
BRIEF published on 03/18/2025 at 18:35, 1 year 7 months ago Oxurion Signs Letter of Intent for Acquisition of Biometrics-Focused CRO Regulatory Compliance Oxurion Acquisition Biometrics CRO Clinical Data Management ECRF Platform
BRIEF published on 03/18/2025 at 18:35, 1 year 7 months ago Oxurion signe une lettre d'intention pour l'acquisition d'une CRO spécialisée dans la biométrie Conformité Réglementaire Acquisition D'Oxurion CRO Biométrique Gestion Des Données Cliniques Plateforme ECRF
PRESS RELEASE published on 03/18/2025 at 18:30, 1 year 7 months ago Oxurion signs a letter of intent for the planned acquisition of a biometrics-focused CRO Oxurion NV plans to acquire majority stake in a specialized CRO for clinical data management. Strategic move aligns with company's expansion strategy. Transaction valued at €650,000 Acquisition CRO Biometric Analysis Oxurion NV Clinical Data Management
Published on 11/10/2026 at 02:45, 4 hours 50 minutes ago Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 8 hours 25 minutes ago Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 8 hours 35 minutes ago LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 9 hours 3 minutes ago Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 11/09/2026 at 22:15, 9 hours 20 minutes ago Goldcliff Announces Closing of the Second and Final Tranche of its "LIFE" Offering and Completion of Drilling at Kettle Valley
Published on 11/10/2026 at 07:23, 11 minutes ago Cantourage Group SE Strengthens Profitability and European Market Position Despite Increasing Pricing Pressure
Published on 11/10/2026 at 07:16, 19 minutes ago FRIEDRICH VORWERK expands into North America: 5C-Tech establishes joint venture 5C-Tech Americas for automated pipeline welding in the U.S.
Published on 11/10/2026 at 07:05, 29 minutes ago Medios Achieves Solid Revenue Growth in a Challenging Market Environment and Confirms Full-Year Forecast
Published on 11/10/2026 at 07:05, 29 minutes ago More than 80% of Dutch consumers consider clothing recycling important, but fewer than half believe clothing donated is recycled, says research conducted by Reju
Published on 11/10/2026 at 07:05, 29 minutes ago Shanghai Electric Integrates Industrial AI into Heavy-Duty Gas Turbine Manufacturing and Lifecycle Services
Published on 11/10/2026 at 07:00, 35 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/10/2026 at 07:00, 35 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine et le marquage CE selon l’IVDR pour VITEK® PRO, son nouvel instrument automatisé d’identification et d’antibiogramme contribuant à la lutte contre l’antibiorésistance
Published on 11/09/2026 at 18:30, 13 hours 5 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 18:30, 13 hours 5 minutes ago Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 390 millions de CHF
